Reste Laboratories to Partner with Roche Diagnostics to

Revolutionise Patient Care in Asia Pacific and Europe

–

This strategic collaboration aims to improve healthcare outcomes through the establishment of a Centre of Excellence and the advancement of digital healthcare transformation.

–

[Singapore, 15th April 2025] Reste Laboratories have signed a Memorandum of Understanding (MOU) with Roche Diagnostics to drive more efficient, accessible, and patient-centric healthcare solutions. By combining ResteLab’s local expertise in cutting-edge laboratory technologies with Roche’s global leadership in diagnostics, this partnership aims to improve the quality of patient care.

The partnership is set to drive meaningful change by also establishing a Centre of Excellence which will focus on research, training, and bringing forward-thinking healthcare solutions to the forefront. The collaboration also aims to fast-track digital solutions like AI-powered diagnostics and telemedicine to make care more accessible and impactful.

“Changing the legacy healthcare system is a challenge, but together with Roche, we believe we can create lasting, transformative solutions,” said Zaccheus Peh, CEO of ResteLab. “This partnership will enable us to deliver real value to patients and healthcare providers while advancing the future of diagnostics and care delivery.”

In the presence of Ms. Cindy Khoo, Managing Director of Enterprise Singapore, and Mr. Lance Little, Head of Region of Roche Diagnostics Asia Pacific, the MOU was signed by Mr. James Linehan, International Key Account Management Lead of Roche Diagnostics Asia Pacific, and Mr. Zaccheus Peh, CEO of ResteLab.

“This partnership with ResteLab marks a significant milestone in Roche’s commitment to transforming healthcare in Asia Pacific and Europe,” said Lance Little, Head of Region of Roche Diagnostics Asia Pacific. “This collaboration is particularly timely, as healthcare systems in Asia Pacific are undergoing rapid transformation. By leveraging Roche’s diagnostic capabilities and ResteLab’s technological advancements, the partnership aims to address the growing need for innovative, scalable solutions that improve patient outcomes, reduce healthcare costs, and ensure better access to care for underserved populations.”

Cindy Khoo, Managing Director of Enterprise Singapore shared, “This partnership between ResteLab and Roche marks an important step in enhancing diagnostics through innovative and effective testing solutions. Many Singapore biomedical companies like ResteLab possess specialised offerings that can contribute to the demands of the global healthcare industry. We want to foster more of such win-win collaborations that unite expertise, technologies and networks, to drive advancements in precision medicine in Singapore and beyond.”

By working together, Roche and ResteLab are poised to drive positive, lasting change in healthcare, improving patient outcomes, and ensuring better, more equitable access to care.

–

–

About ResteLab

Reste Laboratories (ResteLab) was incorporated in 2016.

From its humble beginnings as a small laboratory set-up in eastern part of Singapore, ResteLab grew organically and swiftly gained market share in its territory. Fifth year into operations, ResteLab embarked on its aggressive growth plan and expanded its facility by multiple folds. It currently operates a world-class laboratory spanning over 18,000 square feet in Toa Payoh, centrally located in Singapore.

Since its establishment, ResteLab has consistently delivered efficient, accurate, and high-quality diagnostic results, while adhering to stringent laboratory protocol. This commitment is exemplified by its early adoption of the smart lab concept and close partnership with reputable brands such as Abbott, Roche, and Siemens.

ResteLab serves a diverse clientele, including corporate health screeners, medical clinics, and research institutes. Backed by a dedicated team of industry experts with over 100 years of collective experience and skilled laboratory professionals, the company continuously works to expand its comprehensive suite of routine and specialised diagnostic tests to meet evolving healthcare needs.

Driven by its dedication to excellence and innovation, ResteLab strives to be a leading laboratory services provider in Southeast Asia, delivering high-quality, affordable, and patient-centric diagnostic solutions.

Media contact:

Email: connect@restelab.com